We are live on ! Find out more
CC

Centiva Capital Portfolio holdings

AUM $11.5B
1-Year Est. Return 31.97%
This Fund
S&P 500
This Quarter Est. Return
+3.71%
1 Year Est. Return
+31.97%
3 Year Est. Return
+65.13%
5 Year Est. Return
+86.06%
10 Year Est. Return
AUM
$4.1B
AUM Growth
-$119M
Cap. Flow
+$125M
Cap. Flow %
3.05%
Top 10 Hldgs %
32.52%
Holding
2,416
New
701
Increased
462
Reduced
447
Closed
707

Sector Composition

Rank Sector Weight
1 Miscellaneous 70.44%
2 Financials 6.1%
3 Technology 5.03%
4 Industrials 3.82%
5 Consumer Discretionary 3.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KVACW
1676
DELISTED
Keen Vision Acquisition Corp Warrant
KVACW
$6.25K ﹤0.01%
125,000
ANSCW
1677
DELISTED
Agriculture & Natural Solutions Acquisition Corp Warrant
ANSCW
$6K ﹤0.01%
+37,500
New +$6.51K
ATMCW
1678
DELISTED
AlphaTime Acquisition Corp Warrant
ATMCW
$6K ﹤0.01%
200,000
GLSTR
1679
DELISTED
Global Star Acquisition, Inc. Right
GLSTR
$5.52K ﹤0.01%
78,828
DISTR
1680
DELISTED
Distoken Acquisition Corporation Right
DISTR
$5.4K ﹤0.01%
60,000
VLY icon
1681
PUT
Valley National Bancorp
VLY
$7.69B
$4.78K ﹤0.01%
+600
New +$5.35K
JNJ icon
1682
Johnson & Johnson
JNJ
$646B
$4.75K ﹤0.01%
30
-6,465
-100% -$1.03M
BLEUW
1683
DELISTED
bleuacacia ltd Warrants
BLEUW
$4.49K ﹤0.01%
224,451
TVGNW icon
1684
Tevogen Inc Warrant
TVGNW
$962K
$2.94K ﹤0.01%
42,029
BUJAR
1685
DELISTED
Bukit Jalil Global Acquisition 1 Ltd. Rights
BUJAR
$2.4K ﹤0.01%
10,000
ZLSWW
1686
DELISTED
Zalatoris II Acquisition Corp Warrant
ZLSWW
$2.27K ﹤0.01%
56,709
OSRHW
1687
DELISTED
OSR Health Warrant
OSRHW
$2K ﹤0.01%
100,000
GSAT icon
1688
CALL
Globalstar
GSAT
$10.6B
$1.62K ﹤0.01%
+73
New +$1.77K
GLSTW
1689
DELISTED
Global Star Acquisition, Inc. Warrants
GLSTW
$1.58K ﹤0.01%
78,828
NVACW
1690
DELISTED
NorthView Acquisition Corporation Warrant
NVACW
$1.45K ﹤0.01%
29,061
DISTW
1691
DELISTED
Distoken Acquisition Corporation Warrant
DISTW
$982 ﹤0.01%
49,080
ISRLW
1692
DELISTED
Israel Acquisitions Corp Warrant
ISRLW
$895 ﹤0.01%
12,787
RVNC
1693
PUT
DELISTED
Revance Therapeutics, Inc.
RVNC
$492 ﹤0.01%
100
PHYT.WS
1694
DELISTED
Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
PHYT.WS
$320 ﹤0.01%
10,650
AA icon
1695
CALL
Alcoa
AA
$13.3B
-15,000
Closed -$510K
AA icon
1696
Alcoa
AA
$13.3B
-3,958
Closed -$135K
ABAT icon
1697
American Battery Technology Co
ABAT
$351M
-13,452
Closed -$63.1K
ABBV icon
1698
PUT
AbbVie
ABBV
$451B
-7,200
Closed -$1.12M
ABCB icon
1699
Ameris Bancorp
ABCB
$5.74B
-4,489
Closed -$238K
ABG icon
1700
Asbury Automotive
ABG
$3.8B
-5,755
Closed -$1.29M

Similar funds

Centiva Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Centiva Capital held 2,416 positions worth $4.1B, down 2.8% from $4.21B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Centiva Capital deployed $125M of net new capital in Q1 2024, opening 701 new positions and adding to 462 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,452,706 shares worth $267M.

By sector, the portfolio is most concentrated in Miscellaneous at 70% of assets, down from 74% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was iShares National Muni Bond ETF, an estimated $145M trimmed.

  • Centiva Capital's largest Q1 2024 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,452,706 shares worth $267M.
  • Centiva Capital added most to US Steel in Q1 2024, an estimated $10.2M increase.
  • Centiva Capital's biggest Q1 2024 reduction was iShares National Muni Bond ETF, cutting an estimated $145M.
  • Centiva Capital fully exited Splunk Inc in Q1 2024, selling an estimated $55.8M.
  • Centiva Capital's ten largest holdings make up 33% of its $4.1B portfolio in Q1 2024.
  • Centiva Capital opened 701 new positions and closed 707 in Q1 2024.
  • Centiva Capital's portfolio value fell 2.8% quarter-over-quarter to $4.1B.

Based on Centiva Capital's 13F filing for Q1 2024, filed 15 May 2024.